Oncology and immunotherapy
The sponsor funds studies in hepatocellular carcinoma, biliary tract carcinoma, glioblastoma, colorectal cancer, and melanoma, with strong interest in immune checkpoint inhibition, therapeutic cancer vaccines, and combinations with anti-angiogenic therapy or chemotherapy.
- Hepatocellular carcinoma
- Glioblastoma
- Colorectal cancer
- Cutaneous melanoma
- Biliary tract carcinoma
Research activity also includes metastatic disease, unresectable tumors, and neoadjuvant or maintenance immunotherapy strategies.
Digestive system and gastrointestinal cancer surgery
Clinical work in colorectal surgery and esophageal cancer focuses on surgical outcomes, perioperative support, and treatment intensification for advanced gastrointestinal malignancies, including anal canal cancer and esophageal carcinoma.
- Colorectal surgery
- Esophageal cancer
- Anal canal cancer
- Metastatic colorectal carcinoma
Topics include anastomotic integrity, chemoradiotherapy, and multimodal treatment for locally advanced digestive tumors.
Urologic oncology and renal transplantation
The sponsor supports research in penile squamous cell carcinoma and kidney transplantation, combining interest in cancer treatment with post-transplant care and immune-related complications.
- Penile squamous cell carcinoma
- Renal transplant
- Post-transplant diabetes
- Immunosuppression
Research also addresses lymphocyte depletion prevention and metabolic follow-up after transplantation.
Cardiology and heart failure
One area of interest is chronic decompensated heart failure in older adults, with attention to early treatment pathways in the emergency setting and cardiometabolic management.
- Chronic decompensated heart failure
- Emergency department care
- Gliflozin therapy
- Elderly patients
Work in this field connects cardiovascular disease with practical inpatient and outpatient care transitions.
Renal disease and metabolic complications
The sponsor is involved in studies of renal insufficiency and transplantation-related metabolic risk, including prevention of new-onset diabetes after kidney transplantation.
- Renal insufficiency
- Kidney transplantation
- Post-transplant diabetes
- Metabolic monitoring
These studies reflect interest in renal function, transplant follow-up, and endocrine complications in immunologically vulnerable patients.
